If you’re attending next week’s World Orphan Drug Congress, April 22-24 in Washington, DC, be sure to check out Premier Research. We’re a platinum sponsor of the fifth annual event, more than ever a top meeting place for biopharma, biotechs, government, patient groups, and more.
In addition to showcasing our hands-on rare disease expertise, Premier Research will present a speaker and host two roundtable discussions.
On April 23, hear Emily Stube, Director, Medical Writing Services, Global Regulatory Affairs, talk about attaining expedited review approvals and agreements for Phase 3 orphan drug development programs.
Also on the 23rd, attend the roundtable discussion and get insights on running successful rare disease studies from Angi Robinson, Executive Director and Scientific Account Leader, and other industry experts.
And on April 24,Nach Dave, Director of Regulatory Affairs, leads a roundtable talk on advancing use of regulatory science to aid clinical trial design and performance for pediatric rare diseases.
Premier Research has learned a lot about rare diseases over the course of more than 100 studies. Share in our knowledge at WODC and online through our rare disease resource center.